138 related articles for article (PubMed ID: 2151869)
1. Ultrastructural and electrophysiological alterations during the development of catecholamine-induced cardiac hypertrophy and failure.
Mészáros J; Lévai G
Acta Biol Hung; 1990; 41(4):289-307. PubMed ID: 2151869
[TBL] [Abstract][Full Text] [Related]
2. Study of the factors influencing cardiac growth. II. Digitoxin treatment and isoproterenol-induced cardiac hypertrophy in the rat.
Szabó J; Nosztray K; Takács IE; Szegi J
Acta Biol Hung; 1985; 36(3-4):305-12. PubMed ID: 2436403
[TBL] [Abstract][Full Text] [Related]
3. Chronic blocking of beta 3-adrenoceptor ameliorates cardiac function in rat model of heart failure.
Gan RT; Li WM; Xiu CH; Shen JX; Wang X; Wu S; Kong YH
Chin Med J (Engl); 2007 Dec; 120(24):2250-5. PubMed ID: 18167212
[TBL] [Abstract][Full Text] [Related]
4. Myocardial characteristics of pressure overload hypertrophy. A structural and functional study.
Breisch EA; White FC; Bloor CM
Lab Invest; 1984 Sep; 51(3):333-42. PubMed ID: 6236333
[TBL] [Abstract][Full Text] [Related]
5. Catecholamine induced cardiac hypertrophy.
Tang Q; Taylor PB; Helbing RK
Can J Cardiol; 1987 Sep; 3(6):311-6. PubMed ID: 2962704
[TBL] [Abstract][Full Text] [Related]
6. Cardiomegaly in chronic anemia in ratsman experimental study including ultrastructural, histometric, and stereologic observations.
Datta BN; Silver MD
Lab Invest; 1975 Apr; 32(4):503-14. PubMed ID: 123972
[TBL] [Abstract][Full Text] [Related]
7. Experimental cardiac hypertrophy induced by isoproterenol in the rat.
Szabó J; Csáky L; Szegi J
Acta Physiol Acad Sci Hung; 1975; 46(3):281-5. PubMed ID: 143367
[TBL] [Abstract][Full Text] [Related]
8. [Absence, in the hypertrophied rat heart caused by aortocaval fistula, of several metabolic and electrophysiological changes seen in other models of hypertrophy].
Thollon C; Aussedat J; Verdetti J; Kreher P
C R Acad Sci III; 1985; 300(16):607-12. PubMed ID: 3158383
[TBL] [Abstract][Full Text] [Related]
9. [Dynamic biochemical, metrometric and histomorphological studies in isoproterenol-induced myocardial hypertrophy and its regression in rats].
Prodanov K; Kolarova R; Tsakova L; Balutsov M
Eksp Med Morfol; 1991; 30(1):26-30. PubMed ID: 1832104
[TBL] [Abstract][Full Text] [Related]
10. Myocardial morphological characteristics and proarrhythmic substrate in the rat model of heart failure due to chronic volume overload.
Benes J; Melenovsky V; Skaroupkova P; Pospisilova J; Petrak J; Cervenka L; Sedmera D
Anat Rec (Hoboken); 2011 Jan; 294(1):102-11. PubMed ID: 21157921
[TBL] [Abstract][Full Text] [Related]
11. Quantitative ultrastructural aspects of cardiac hypertrophy.
Tomanek RJ
Tex Rep Biol Med; 1979; 39():111-22. PubMed ID: 162243
[TBL] [Abstract][Full Text] [Related]
12. Repeated daily injections and osmotic pump infusion of isoproterenol cause similar increases in cardiac mass but have different effects on blood pressure.
Hohimer AR; Davis LE; Hatton DC
Can J Physiol Pharmacol; 2005 Feb; 83(2):191-7. PubMed ID: 15791293
[TBL] [Abstract][Full Text] [Related]
13. Effect of ouabain in catecholamine-induced cardiac hypertrophy.
Mészáros J; Pásztor B
Acta Physiol Hung; 1995; 83(1):55-62. PubMed ID: 7660838
[TBL] [Abstract][Full Text] [Related]
14. [Morphologic findings during regression of heart hypertrophy].
Frenzel H
Z Kardiol; 1985; 74 Suppl 7():107-18. PubMed ID: 2936013
[TBL] [Abstract][Full Text] [Related]
15. Changes in sarcolemmal adenosine triphosphatase activity and in ouabain sensitivity of rat myocardium in isoproterenol-induced cardiac hypertrophy.
Szabó J; Nosztray K; Szegi J
Pol J Pharmacol Pharm; 1989; 41(6):553-9. PubMed ID: 2562064
[TBL] [Abstract][Full Text] [Related]
16. Effect of sodium houttuyfonate on myocardial hypertrophy in mice and rats.
Gao JP; Chen CX; Wang Y; Lü J; Gu WL
J Pharm Pharmacol; 2009 May; 61(5):677-83. PubMed ID: 19406008
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of heat shock transcription factor 1 plays a critical role in adaptive cardiac hypertrophy.
Sakamoto M; Minamino T; Toko H; Kayama Y; Zou Y; Sano M; Takaki E; Aoyagi T; Tojo K; Tajima N; Nakai A; Aburatani H; Komuro I
Circ Res; 2006 Dec; 99(12):1411-8. PubMed ID: 17095722
[TBL] [Abstract][Full Text] [Related]
18. Phosphoinositide 3-kinase gamma-deficient mice are protected from isoproterenol-induced heart failure.
Oudit GY; Crackower MA; Eriksson U; Sarao R; Kozieradzki I; Sasaki T; Irie-Sasaki J; Gidrewicz D; Rybin VO; Wada T; Steinberg SF; Backx PH; Penninger JM
Circulation; 2003 Oct; 108(17):2147-52. PubMed ID: 12963636
[TBL] [Abstract][Full Text] [Related]
19. Treatment with atorvastatin partially protects the rat heart from harmful catecholamine effects.
Schmechel A; Grimm M; El-Armouche A; Höppner G; Schwoerer AP; Ehmke H; Eschenhagen T
Cardiovasc Res; 2009 Apr; 82(1):100-6. PubMed ID: 19136528
[TBL] [Abstract][Full Text] [Related]
20. Chronic colchicine administration attenuates cardiac hypertrophy in spontaneously hypertensive rats.
Tsutsui H; Ishibashi Y; Takahashi M; Namba T; Tagawa H; Imanaka-Yoshida K; Takeshita A
J Mol Cell Cardiol; 1999 Jun; 31(6):1203-13. PubMed ID: 10371695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
